(Q43916011)

28 November 2017

title

HEPC-based liposomes trigger cytokine release from peripheral blood cells: effects of liposomal size, dose and lipid composition (English)

1 reference

28 November 2017

Sayaka Yamamoto

1

1 reference

28 November 2017

Tatsuhiro Ishida

2

1 reference

28 November 2017

Akiko Inoue

3

1 reference

28 November 2017

Junko Mikami

4

1 reference

28 November 2017

Masahiro Muraguchi

5

1 reference

28 November 2017

Yasukazu Ohmoto

6

1 reference

28 November 2017

Hiroshi Kiwada

7

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 April 2002

1 reference

International Journal of Pharmaceutics

28 November 2017

published in

1 reference

28 November 2017

volume

236

1 reference

28 November 2017

issue

1-2

1 reference

28 November 2017

page(s)

125-133

1 reference

Lipopolysaccharide, lipid A, and liposomes containing lipid A as immunologic adjuvants

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900026-1

7 January 2021

Identification of the 80-kDa LPS-binding protein (LMP80) as decay-accelerating factor (DAF, CD55).

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900026-1

7 January 2021

Cytokine production in whole bloodex vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900026-1

7 January 2021

Contribution of complement system on destabilization of liposomes composed of hydrogenated egg phosphatidylcholine in rat fresh plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900026-1

7 January 2021

Phase II study of liposomal doxorubicin in platinum- and paclitaxel-refractory epithelial ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900026-1

7 January 2021

Adjuvants for human vaccines--current status, problems and future prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900026-1

7 January 2021

Synthesis, characterization, and some immunological properties of conjugates composed of the detoxified lipopolysaccharide of Vibrio cholerae O1 serotype Inaba bound to cholera toxin

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900026-1

7 January 2021

Adjuvants--a balance between toxicity and adjuvanticity

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900026-1

7 January 2021

Molecular adjuvants and immunomodulators: new approaches to immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900026-1

7 January 2021

Lipopolysaccharide-stimulated TNF-alpha release from cultured rat Kupffer cells: sequence of intracellular signaling pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900026-1

7 January 2021

Correlation of toxicity with pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in metastatic breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900026-1

7 January 2021

Clinical efficacy and prospects for use of pegylated liposomal doxorubicin in the treatment of ovarian and breast cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900026-1

7 January 2021

Liposomal amphotericin B (AmBisome) in the treatment of complicated kala-azar under field conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900026-1

7 January 2021

LPS-Induced NF-kappaB activation and TNF-alpha release in human monocytes are protein tyrosine kinase dependent and protein kinase C independent

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900026-1

7 January 2021

Liposomal doxorubicin: antitumor activity and unique toxicities during two complementary phase I studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900026-1

7 January 2021

Disease-specific ex vivo stimulation of whole blood for cytokine production: applications in the study of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900026-1

7 January 2021

The dual role of lipopolysaccharide as effector and target molecule

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900026-1

7 January 2021

10.1016/S0378-5173(02)00026-1

Identifiers

DOI

1 reference

28 November 2017

1 reference